Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
---|---|---|---|---|---|---|---|---|
MET proto-oncogene, receptor tyrosine kinase in Human [GtoPdb: 1815] [UniProtKB: P08581] | ||||||||
GtoPdb | Inhibition of substrate phosphorylation by human c-MET (residues R974-S1390 with A1209G and V1290L) in vitro | - | 8 | pIC50 | <10 | nM | IC50 | WO2019148044A1. Compounds for the treatment of kinase-dependent disorders (2019) |
AXL receptor tyrosine kinase in Human [GtoPdb: 1835] [UniProtKB: P30530] | ||||||||
GtoPdb | Inhibition of hAxl kinase (residues H473-A894 with Q764R) activity in vitro | - | 8 | pIC50 | <10 | nM | IC50 | WO2019148044A1. Compounds for the treatment of kinase-dependent disorders (2019) |
MER proto-oncogene, tyrosine kinase in Human [GtoPdb: 1837] [UniProtKB: Q12866] | ||||||||
GtoPdb | Inhibition of substrate phosphorylation by hMER (residues R557-E882 with H628Q and R794A) in vitro | - | 8 | pIC50 | <10 | nM | IC50 | WO2019148044A1. Compounds for the treatment of kinase-dependent disorders (2019) |
Our curators have not yet identified this ligand in ChEMBL, but you may find additional data by searching on the ChEMBL site using the ligand's name or structure.